- Home
- KMDA
KMDA
Kamada Ltd.
as 07-26-2024 4:00pm EST
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
| Founded: | 1990 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 325.9M | IPO Year: | N/A |
| Target Price: | $14.50 | AVG Volume (30 days): | 52.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.08 - $6.53 | Next Earning Date: | 08-14-2024 |
| Revenue: | $149,545,000 | Revenue Growth: | 13.33% |
| Revenue Growth (this year): | 14.48% | Revenue Growth (next year): | 12.37% |
Latest Kamada Ltd. News
KMDA Breaking Stock News: Dive into KMDA Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
2 months ago
KMDA: Full Year Guidance Raised; Year-Over-Year Top-Line Growth of 23%…
Insider Monkey
3 months ago
Kamada Ltd. (NASDAQ:KMDA) Q1 2024 Earnings Call Transcript
Associated Press Finance
3 months ago
Kamada: Q1 Earnings Snapshot
GlobeNewswire
3 months ago
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance
GlobeNewswire
3 months ago
Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Zacks Small Cap Research
4 months ago
KMDA: Double Digit Growth Anticipated in 2024 with $158 Million in Expected Revenues and $28 Million in Expected Adjusted EBITDA…
Insider Monkey
5 months ago
Kamada Ltd. (NASDAQ:KMDA) Q4 2023 Earnings Call Transcript
Associated Press Finance
5 months ago
Kamada: Q4 Earnings Snapshot
Compare KMDA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KMDA Kamada Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.